AKINOSOGLOU KAROLINA, Associate Professor

School of Medicine, University of Patras +30 2613 603583, 2610 997254, 2613603699

+306977762897 akin@upatras.gr

Summary of Curriculum Vitae

Karolina Akinosoglou was born in Patras. She studied Medicine at University of Patras, from where she graduated in 2006. She completed her PhD on the field of molecular and cellular immunobiology of malaria parasite at Imperial College London in 2011, while in parallel she gained significant clinical expertise in tropical diseases at Lister Unit of infectious diseases and tropical medicine, at Northwick Park Hospital in London (2006-2010). At the same time, she was trained in modern teaching methods and current trends including PBL (Problem Based Learning), which she successfully implemented for two consecutive years on 1^st and 2^nd year medical students at London Imperial College receiving most positive feedback. Moreover, she was also involved in the supervision of final year under-graduate student assays and post-graduate student master thesis at division of Biology at the same institution (2007-2010). She completed specialization in Internal Medicine and Infectious Diseases, at University Hospital of Patras, in Greece (2017). She presents extensive teaching experience in both under and post graduate level, including academic lead of series of lectures and supervision of master and PhD theses. Her research interests mostly focus in the field of infectious diseases, and specifically during the last years in sepsis and systematic inflammatory response, COVID-19 and HIV, work upon which has been presented in international conferences  and multiply awarded by international scientific societies, while being published in several peer-reviewed journals (>4200 citations, h index:26, i10 index:39).  She has been a reviewer in high impact journals in infectious diseases and member of organizing and steering committee, as well as, invited speaker in several local and national scientific meetings in internal medicine and infectious diseases. She is a member of several national and international scientific societies (IDSA, ASM, ESCMID, GMC, EEMAA, EEL etc.) and has been a member of the board and vice president of Medical Society of Western Greece and Peloponnese.  She engages in clinical work in department of internal medicine and division of infectious diseases at University Hospital of Patras, attending both in and out-patients, leading ward rounds and consultations, including COVID-19 clinic during 2020-2022. She is at the moment working as an Associate Professor in Internal Medicine, at University of Patras and serving as Internist-Infectiologist at University Genera Hospital of Patras

Undergraduate Courses

• Introduction to Clinical Μedicine (Semester: 1st)
• Introduction to Clinical Skills - First Aid (Semester: 2nd)
• Clinical Skills I (Semester: 3rd)
• Clinical Skills II (Semester: 4th)
• Clinical Skills III (Semester: 5th)
• Health Promotion-Disease Prevention-Community Medicine (Semester: 7th)
• Fever of Unknown Origin – Final Stage Patient - Evidence Based Medicine - Oncology - Infectious Diseases (Semester: 7th)
• Internal Medicine (Clinical Training) (Semester: 11th & 12th)
• Infections Diseases (Clinical Training) (Semester: 11th & 12th)

Postgraduate Courses

• Post Graduate Course "Public Health" University of Patras (2015-today) - Academic Lead Series of Lectures in "Methodology of Research", "Tropical Medicine", "Designing a Research Protocol"
• Post Graduate Course "Precision Medicine" University of Patras (2022-today) - Academic Lead Series of Lectures in "Clinical Applications",
• Post Graduate Course "Health Education" University of Patras (2023-today) - Academic Lead Series of Lectures in "Methodology of Research", "Writting Skills"
• Post Graduate Course "Infectious Diseases" National and Kapodistrian University of Athens (2019-today) 
• Post Graduate Course "Respiratory Failure" National and Kapodistrian University of Athens (2022-today) 
• Post Graduate Course "Epidemiology" Hellenic Open University (2022-today) - Academic Lead Series of Lectures in "Clinical Epidemiology",

Selected Publications

• COVID-19 Pharmacotherapy in Pregnancy: A Literature Review of Current Therapeutic Choices.

  Akinosoglou K, Schinas G, Rigopoulos EA, Polyzou E, Tzouvelekis A, Adonakis G, Gogos C.Viruses. 2023 Mar 19;15(3):787. doi: 10.3390/v15030787.

• Upraising Stenotrophomonas maltophilia in Critically Ill Patients: A New Enemy? Dimopoulos G, Garnacho-Montero J, Paramythiotou E, Gutierrez-Pizarraya A, Gogos C, Adriansen-Pérez M, Diakaki C, Matthaiou DK, Poulakou G, Akinosoglou K.Diagnostics (Basel). 2023 Mar 15;13(6):1106.

• National medical specialty guidelines of HIV indicator conditions in Europe lack adequate HIV testing recommendations: a systematic guideline review. Jordans CCE, Vasylyev M, Rae C, Jakobsen ML, Vassilenko A, Dauby N, Grevsen AL, Jakobsen SF, Raahauge A, Champenois K, Papot E, Malin JJ, Boender TS, Behrens GMN, Gruell H, Neumann A, Spinner CD, Valbert F, Akinosoglou K, Kostaki EG, Nozza S, Giacomelli A, Lapadula G, Mazzitelli M, Torti C, Matulionyte R, Matulyte E, Van Welzen BJ, Hensley KS, Thompson M, Ankiersztejn-Bartczak M, Skrzat-Klapaczyńska A, Săndulescu O, Streinu-Cercel A, Streinu-Cercel A, Miron VD, Pokrovskaya A, Hachfeld A, Dorokhina A, Sukach M, Lord E, Sullivan AK, Rokx C; Guidelines Review Group for the projects: Optimising testing and linkage to care for HIV across Europe (OptTEST by HiE) and the Joint Action on integrating prevention, testing and linkage to care strategies across HIV, viral hepatitis, TB and STIs in Europe (INTEGRATE).Euro Surveill. 2022 Dec;27(48):2200338. 

• Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study).Pascale R, Toschi A, Aslan AT, Massaro G, Maccaro A, Fabbricatore D, Dell'Aquila A, Ripa M, Işık ME, Kızmaz YU, Iacopino S, Camici M, Perna F, Akinosoglou K, Karruli A, Papadimitriou-Olivgeris M, Kayaaslan B, Bilir YA, Evren Özcan E, Turan OE, Işık MC, Pérez-Rodríguez MT, Yagüe BL, Quirós AM, Yılmaz M, Petersdorf S, De Potter T, Durante-Mangoni E, Akova M, Curnis A, Gibertoni D, Diemberger I, Scudeller L, Viale P, Giannella M; CarDINe Study Group.Int J Antimicrob Agents. 2023 Mar;61(3):106734.

•  

  Oral minocycline plus rifampicin versus oral linezolid for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: The AIDA open label, randomized, controlled Phase 4 trial.Kotsaki A, Tziolos N, Kontopoulou T, Koutelidakis IM, Symbardi S, Reed V, O'Hare M, Alexiou Z, Sambatakou H, Toutouzas K, Akinosoglou K, Lada M, Giamarellos-Bourboulis EJ, MacGowan A.EClinicalMedicine. 2022 Dec 26;56:101790. 

• Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial.Akinosoglou K, Kotsaki A, Gounaridi IM, Christaki E, Metallidis S, Adamis G, Fragkou A, Fantoni M, Rapti A, Kalomenidis I, Chrysos G, Boni G, Kainis I, Alexiou Z, Castelli F, Serino FS, Bakakos P, Nicastri E, Tzavara V, Safarika A, Ioannou S, Dagna L, Dimakou K, Tzatzagou G, Chini M, Bassetti M, Kotsis V, Angheben A, Tsoukalas G, Selmi C, Spiropoulou OM, Samarkos M, Doumas M, Damoraki G, Masgala A, Papanikolaou I, Argyraki A, Negri M, Leventogiannis K, Sympardi S, Gatselis NK, Petrakis V, Netea MG, Panagopoulos P, Sakka V, Milionis H, Dalekos GN, Giamarellos-Bourboulis EJ.EClinicalMedicine. 2023 Feb;56:101785. doi: 10.1016/j.eclinm.2022.101785.

• The impact of age on intensive care. Akinosoglou K, Schinas G, Almyroudi MP, Gogos C, Dimopoulos G.Ageing Res Rev. 2023 Feb;84:101832

• Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review. Almyroudi MP, Akinosoglou K, Rello J, Blot S, Dimopoulos G.Diagnostics (Basel). 2022 Dec 8;12(12):3092.

• Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia. Samaras C, Kyriazopoulou E, Poulakou G, Reiner E, Kosmidou M, Karanika I, Petrakis V, Adamis G, Gatselis NK, Fragkou A, Rapti A, Taddei E, Kalomenidis I, Chrysos G, Bertoli G, Kainis I, Alexiou Z, Castelli F, Saverio Serino F, Bakakos P, Nicastri E, Tzavara V, Kostis E, Dagna L, Koukidou S, Tzatzagou G, Chini M, Bassetti M, Trakatelli C, Tsoukalas G, Selmi C, Samarkos M, Pyrpasopoulou A, Masgala A, Antonakis E, Argyraki A, Akinosoglou K, Sympardi S, Panagopoulos P, Milionis H, Metallidis S, Syrigos KN, Angel A, Dalekos GN, Netea MG, Giamarellos-Bourboulis EJ.Cytokine. 2023 Feb;162:156111.

• Oral Antiviral Treatment for COVID-19: A Comprehensive Review on Nirmatrelvir/Ritonavir. Akinosoglou K, Schinas G, Gogos C.Viruses. 2022 Nov 17;14(11):2540.

• Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial. Leventogiannis K, Kyriazopoulou E, Antonakos N, Kotsaki A, Tsangaris I, Markopoulou D, Grondman I, Rovina N, Theodorou V, Antoniadou E, Koutsodimitropoulos I, Dalekos G, Vlachogianni G, Akinosoglou K, Koulouras V, Komnos A, Kontopoulou T, Prekates A, Koutsoukou A, van der Meer JWM, Dimopoulos G, Kyprianou M, Netea MG, Giamarellos-Bourboulis EJ.Cell Rep Med. 2022 Nov 15;3(11):100817.

• Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia. Petrakis V, Rapti V, Akinosoglou K, Bonelis C, Athanasiou K, Dimakopoulou V, Syrigos NK, Spernovasilis N, Trypsianis G, Marangos M, Gogos C, Papazoglou D, Panagopoulos P, Poulakou G.Microorganisms. 2022 Sep 30;10(10):1949.

• Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial. Karampitsakos T, Papaioannou O, Tsiri P, Katsaras M, Katsimpris A, Kalogeropoulos AP, Malakounidou E, Zarkadi E, Tsirikos G, Georgiopoulou V, Sotiropoulou V, Koulousousa E, Chourpiliadi C, Matsioulas A, Lagadinou M, Sampsonas F, Akinosoglou K, Marangos M, Tzouvelekis A.Clin Microbiol Infect. 2023 Mar;29(3):372-378.

• ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk. Tsilika M, Taks E, Dolianitis K, Kotsaki A, Leventogiannis K, Damoulari C, Kostoula M, Paneta M, Adamis G, Papanikolaou I, Stamatelopoulos K, Bolanou A, Katsaros K, Delavinia C, Perdios I, Pandi A, Tsiakos K, Proios N, Kalogianni E, Delis I, Skliros E, Akinosoglou K, Perdikouli A, Poulakou G, Milionis H, Athanassopoulou E, Kalpaki E, Efstratiou L, Perraki V, Papadopoulos A, Netea MG, Giamarellos-Bourboulis EJ.Front Immunol. 2022 Jul 5;13:873067.

• Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failure. Giamarellos-Bourboulis EJ, Poulakou G, de Nooijer A, Milionis H, Metallidis S, Ploumidis M, Grigoropoulou P, Rapti A, Segala FV, Balis E, Giannitsioti E, Rodari P, Kainis I, Alexiou Z, Focà E, Lucio B, Rovina N, Scorzolini L, Dafni M, Ioannou S, Tomelleri A, Dimakou K, Tzatzagou G, Chini M, Bassetti M, Trakatelli C, Tsoukalas G, Selmi C, Samaras C, Saridaki M, Pyrpasopoulou A, Kaldara E, Papanikolaou I, Argyraki A, Akinosoglou K, Koupetori M, Panagopoulos P, Dalekos GN, Netea MG.Cell Rep Med. 2022 Feb 25;3(3):100560. doi: 10.1016/j.xcrm.2022.100560. eCollection 2022 Mar 15.

• Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT Study. Akinosoglou K, Savopoulos C, Pouliakis A, Triantafyllidis C, Markatis E, Golemi F, Liontos A, Vadala C, Papanikolaou IC, Dimakopoulou V, Xarras P, Varela K, Kaiafa G, Mitsianis A, Chatzistamati A, Randou E, Savvanis S, Pavlaki M, Efraimidis G, Samaras V, Papazoglou D, Konstantinidou A, Panagopoulos P, Milionis H, On Behalf Of The Interact Study Group.Viruses. 2022 Apr 7;14(4):767.

• Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study. Karampitsakos T, Malakounidou E, Papaioannou O, Dimakopoulou V, Zarkadi E, Katsaras M, Tsiri P, Tsirikos G, Georgiopoulou V, Oikonomou I, Davoulos C, Velissaris D, Sampsonas F, Marangos M, Akinosoglou K, Tzouvelekis A.Respir Res. 2021 Dec 22;22(1):317

• Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays. Fotis C, Meimetis N, Tsolakos N, Politou M, Akinosoglou K, Pliaka V, Minia A, Terpos E, Trougakos IP, Mentis A, Marangos M, Panayiotakopoulos G, Dimopoulos MA, Gogos C, Spyridonidis A, Alexopoulos LG.Sci Rep. 2021 Mar 23;11(1):6614

• Elements of Th1/Th2 response and disease severity in COVID-19 patients: A short report. Akinosoglou K, Delastic AL, Dimakopoulou V, Marangos M, Gogos C.J Med Virol. 2022 Jan;94(1):404-406. doi: 10.1002/jmv.27313

• Patient-reported outcomes in HIV clinical trials evaluating antiretroviral treatment: a systematic review. Akinosoglou K, Antonopoulou S, Katsarolis I, Gogos CA.AIDS Care. 2021 Sep;33(9):1118-1126.

•  Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study. Karaiskos I, Daikos GL, Gkoufa A, Adamis G, Stefos A, Symbardi S, Chrysos G, Filiou E, Basoulis D, Mouloudi E, Galani L, Akinosoglou K, Arvaniti K, Masgala A, Petraki M, Papadimitriou E, Galani I, Poulakou G, Routsi C, Giamarellou H; Hellenic Ceftazidime/Avibactam Registry Study Group.J Antimicrob Chemother. 2021 Feb 11;76(3):775-783

• Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure. Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, Damoraki G, Gkavogianni T, Adami ME, Katsaounou P, Ntaganou M, Kyriakopoulou M, Dimopoulos G, Koutsodimitropoulos I, Velissaris D, Koufargyris P, Karageorgos A, Katrini K, Lekakis V, Lupse M, Kotsaki A, Renieris G, Theodoulou D, Panou V, Koukaki E, Koulouris N, Gogos C, Koutsoukou A.Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3. 

• Diabetes on sepsis outcomes in non-ICU patients: A cohort study and review of the literature. Akinosoglou K, Kapsokosta G, Mouktaroudi M, Rovina N, Kaldis V, Stefos A, Kontogiorgi M, Giamarellos-Bourboulis E, Gogos C; Hellenic Sepsis Study Group.J Diabetes Complications. 2021 Jan;35(1):107765. 

• Biomarkers in pediatric sepsis: a review of recent literature. Z Oikonomakou M, Gkentzi D, Gogos C, Akinosoglou K.Biomark Med. 2020 Jul;14(10):895-917. 

•  

  Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus. Renieris G, Katrini K, Damoulari C, Akinosoglou K, Psarrakis C, Kyriakopoulou M, Dimopoulos G, Lada M, Koufargyris P, Giamarellos-Bourboulis EJ.Shock. 2020 Nov;54(5):633-637.

• Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia. Rovina N, Akinosoglou K, Eugen-Olsen J, Hayek S, Reiser J, Giamarellos-Bourboulis EJ.Crit Care. 2020 Apr 30;24(1):187. 

• Could the Quick Sequential Organ Failure Assessment Predictive Accuracy Be Affected by Site of Infection? Akinosoglou K, deLastic AL, Niarou V, Ziazias D, Davoulos C, Kolosaka M, Kosmopoulou F, Theodoraki S, Koutsouri CP, Gogos C.Am J Respir Crit Care Med. 2020 Jul 1;202(1):153-154.

• Progression into sepsis: an individualized process varying by the interaction of comorbidities with the underlying infection. Sinapidis D, Kosmas V, Vittoros V, Koutelidakis IM, Pantazi A, Stefos A, Katsaros KE, Akinosoglou K, Bristianou M, Toutouzas K, Chrisofos M, Giamarellos-Bourboulis EJ.BMC Infect Dis. 2018 May 29;18(1):242.

 

Selected Presentations

● «Navigating the journey for patients with COVID-19» Joint European of Internal Medicine and the International Congress of Internal Meicine  15-18/03/2023 Athens ● «Colistin: Is it still an option? » 1st Conference on BloodStream Infections, European Shock Society, ESCMID & Italian Society for Microbiology, Italy 14-16/06/2020 ● Platelets and anti-platelets in sepsis’ XVIII congress of the European Shock Society and IXth congress of the International Federation of Shock Societies, Chania 08-12/10/2019●“Viral Loads and CD4 counts are not important for initiating antiretroviral therapy”, CD4 count and Baseline HV-RNA, HIV Deep Dive, Gilead Sponsored Webinar July 2021 ●Biomarkers in Sepsis Biennally Symposium in Critically ill Patients, Salonica 07-10/04/2022 Thessaloniki

● Invited Speaker in > 150 Greek Panhellenic or Local Conferences /Meetings in Internal Medicine and Infectious Diseases and Industry Sponsored events in the same context

PhD Theses Advisor

• Dr S.Theodoraki «Platelet Reactivity along different stages of sepsis»  1917/10427/29-03-2018 University of Patras - completed 
• Dr Μ.Kolosaka «Platelet Reactivity in PLWHIV» 1916/10425/29-03-2018 Medical School University of Patras
• Dr C.P.Koutsouri «Studying Patterns, Predictors and Costs associated with successful outcomes following empiric antibiotic therapy" 3036/20034/27-06-2019 Medical School University of Patras
• Ms Α.Skintzi «Immunogic Response, outcomes and cost in bacteremias due to antibiotic sensitive vs antibiotic resistant pathogens" 3038/20045/27-06-2019Medical School University of Patras
• Dr Nikolina Antonopoulou "HEV prevelance in PLWHIV in Greece and associated PROs» 1539/11042/31.3.2020 Medical School University of Patras
• Dr V.Dimakopoulou  'Immunologic Profiling in pts with COVID-19' 10.11.2020 Medical School University of Patras
• Dr G.Schinas «PRL dysregulation in COVID-19 pts receiving JAK1/2 inhibitors»  837/18.07.2022 Medical School University of Patrasν
• Dr GI Hampaios  'Lipidomic profiling and associated immune response in pts with COVID-19"834/20.06.2022  Medical School University of Patras

Other Activities

DISTINCTIONS, FELLOWSHIPS, HONORS
2003-2005 State Scholarship Foundation, Fellowship for Excellent Academic Performance
2003- 2005 Onassis Foundation, Science Lecture Series in Biology Fellowship (FORTH)
2007-2010 Leventis Foundation, Scholarship for Post Graduate Studies
2015 International Society of Chemotherapy - Young Investigator Travel Award
2016, 2017 ESCMID attendance grants for courses and poster presentations
2017 EACS scholarship for HIV Summer School 2017 attendance
2017,2022 1st prize “Sotiris Papastamatis” (23rd & 23rd Panhell. Conference in Internal Medicine)
2018,2020 EACS Young Investigator Scholarship Conferences Brussels 2018/2020
2018 Infectious Diseases Fellow Program, ASM Microbe 2018
2018,2021 ISHEID Marseille attendance - travel grant
2020 International AIDS Scholarship Award, 23rd International AIDS Conference

RESEARCH GRANTS
2013-2015 Hellenic Institute for Sepsis (PRESS study)
2016-2018 Gilead Research Grant: Asklepios  (PRE-PART study)
2020-2022 Gilead Research Grant: Asklepios  “THE SHIP study)
2020-2022 Gilead Research Grant: Asklepios  “Tregs in patients with HIV”
2019-2021 University of Patras Research Grant: Karatheodoris 30.000€ (PREP-ART)

RESEARCH EXPERIENCE (Selection)
Sub-investigator in 17 multicentre clinical trials including NCT01231516, NCT01644643, NCT02202135, NCT02111564, NCT02725866, COMBACTE-CARE; EURECA, EudraCT 2014-001276-56:AIDA/HSSG, NCT02573571, NCT03332225, NCT02133131, NCT0371735, NCT03595553, NCT03717350, EudraCT 2020-001039-29, EudraCT 2020-001466-11 Principal Investigator in Investigator-initiated projects and multicentre studies: NCT04315948, NCT04680949, NCT02562261, NCT04805671, NCT05036824, NCT04725123 , NCT04889040, NCT05279352. PRE-PART, NCT04724044, THE SHIP study, : CarDINe study & Epidemiological Studies  - Consulting Physician in INTERREG, COOFCHEA 2* GCP latest completion: ICH GCP (E6) July 2022

CONTRIBUTION IN BOOKS 
Κ.Akinosoglou Urinary Tract Infections in Diagnostic and Therapeutic Approach in Primary Care EOF, ISBN 978-618-83768-0-9●Akinosoglou K & Gogos CA Urogenital Infections, In Management of Infections in Primary Care Units, by National Organization for Medicines 2014, p27-43, Athens ● Akinosoglou K Evidence Based Medicine, In Quality in Health Services Athens; Parisianou Publications 2006 ISBN: 978-960-394-442-3 ● Akinosoglou K & Gogos C “on Call”, Pocket Book for young doctors and residents ISBN: 978-960-9427-71-5 ● K.Akinosoglou & Gogos C: CMV, EBV, HSV, HIV & Liver Disease, in Clinical Hepatology Athens 2019 ISBN 9786188458109 ● K.Akinosoglou & Gogos C: Infection and Sepsis : Clostridium difficile Athens 2020 ISBΝ 978-618-85497-0-8

ABSTRACTS IN INTERNATIONAL MEETINGS
●Georgiopoulou et al # 04597 ECCMID 2023 ●Schinas et al # 00563 ECCMID 2023 ● Akinosoglou et al # 1939 ECIM 2023 ● Salourou et al # 1244 ECIM 2023 ● Polyzou et al # 1259 ECIM 2023● Tsoupra et al # 1516 ECIM 2023 ● Schinas et al # 1260 ECIM 2023 ● Kolosaka et al ΕΡΒ127 AIDS July 2022 Montreal Canada ●Jordans et al (AS-EACS-20221-00317 ●Schinas et al # 03896 ECCMID 2022 ●E Giamarellos et al 03490 ECCMID 2022 ●R.Pascale et al CarDINe study # 01621 ECCMID 2022 ● K.Akinosoglou, et al #A-AIDS2020-02196 23rd International AIDS Conference AIDS 2020, San Francisco USA 6-10 July 2020 ● K.Akinosoglou, et al # 4676 ASM Microbe-ICAAC, Chicago June 2020K.Akinosoglou, et al # 3729 ASM Microbe-ICAAC, Atlanta 2018 ● Akinosoglou K, et al # 352 ECCMID Madrid 2018 ● K.Akinosoglou, et al # 3272 ASM Microbe-ICAAC, New Orleans June 2017 ● K.Akinosoglou, et al # 2864 ASM Microbe-ICAAC, New Orleans June 2017 ● K.Akinosoglou, et al # 2841 ASM Microbe-ICAAC, New Orleans June 2017 ● K.Akinosoglou, et al # 597 ECCMID Vienna 2017 ● Akinosoglou K, et al” # 642 ECCMID Vienna 2017 ● Akinosoglou K, et al # B-520 ICAAC/ICC San Diego CA 2015 ● Akinosoglou Ket al # 4173, ECCMID Amsterdam 2016 ● Ukegbu V, et al. 6th EMBO Meeting on Molecular and Population Biology of Mosquitoes and Other Disease Vectors, Crete, Greece, 2013. Pathogens and Global Health 107, no. 8 (2013): 402 ● Akinosoglou K, et al. 8th Annual BioMalPar Conference, Heidelberg, Germany,2012 ● Harris C et al 60th Annual Meeting, American Society of Tropical Medicine and Hygiene (ASTMH), Philadelphia, PA, USA, December 2011. ● Mendes A, et al. 4th EMBO Meeting on Molecular and Population Biology of Mosquitoes and Other Disease Vectors, Kolymbari, Crete, Greece, 2009

REVIEWER IN PEER-REVIEWED JOURNALS
BMC Infectious Diseases; Canadian Medical Association Journal; Critical Care; Clinical Infectious Diseases; Plos One; Journal of Global Antimicrobial Resistance; Scientific Reports; Blood; Viruses; Cytokine; HIV medicine; Microorganisms; International Journal of Infectious Diseases; Sexually Transmitted Diseases; Viruses; European Journal of Clinical Microbiology; Journal of Medical Virology

EDITOR IN PEER-REVIEWED JOURNALS
Viruses; Microorganisms; 

MEMBER OF SCIENTIFIC COMMUNITIES / BOARDS
IDSA; ESCMID; ASM; GMC; Hellenic Society of Infectious Diseases; Hellenic Society for the Study and Management of AIDS; Hellenic Institute for the Study of Sepsis; Scientific Society of Western Greece; Hellenic Institute of Infections in Diabetic Patients; ESCMID Study Group on bacteremia, endocarditis and sepsis; EACS; IAS

MEMBER OF EDUCATIONAL COMMITTEES/ BOARDS
Member of Steering Committees of
1) Quality Assessment and Validation of University of Patras Medical School Undergraduate Curriculum (200/3548/5-2-18)   2) Foundation of Postgraduate Interdepartmental Course in Personalized Medicine, Dept of Medicine and Pharmacology, (69/20.12.2017 University of Patras) 3) National Planning of HIV Management: Co-ordinating working group on self-testing  4) Laboratory of Molecular Diagnosis of Infectious Diseases 18/9188/12.3.2020, University of Patras  5) Elected Scientific Board Member, University Hospital of Patras 2020-2022  6) Appointed Member of Hospital Acquired Infection Committee 2021-2023 7) Ethics Research Committee 2021-2023, University of Patras 8) Appointed Member of COVID-19 committee University Hospital of Patras
9) Appointed Member for infection consultation on COVID-19 for 6th Health Region 10) Appointed consultant of Hellenic Agency for Quality Assurance in Health Society for Safety Issues 2021-today 11) Steering Committee of PostGraduate Courses of "Public Health"and "Precision Medicine" 2022-today 12) Steering Committee of undergraduate curriculum, Medical School, University of Patras (2023-2024)

Member Of Organising – Scientific Committees Of Several Panhellenic And Local Meetings In Internal Medicine, Infectious Diseases And HIV